KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Other Non-Current Liabilities (2016 - 2025)

Pfizer (PFE) has disclosed Other Non-Current Liabilities for 17 consecutive years, with $13.9 billion as the latest value for Q2 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 113.27% to $13.9 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $13.9 billion, a 113.27% increase, with the full-year FY2024 number at $14.2 billion, up 65.81% from a year prior.
  • Other Non-Current Liabilities was $13.9 billion for Q2 2025 at Pfizer, down from $14.2 billion in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $14.2 billion in Q4 2023 to a low of $5.9 billion in Q3 2024.
  • A 5-year average of $10.6 billion and a median of $10.7 billion in 2022 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: tumbled 58.54% in 2024, then surged 113.27% in 2025.
  • Pfizer's Other Non-Current Liabilities stood at $9.7 billion in 2021, then skyrocketed by 35.28% to $13.2 billion in 2022, then tumbled by 35.25% to $8.5 billion in 2023, then skyrocketed by 65.81% to $14.2 billion in 2024, then fell by 1.55% to $13.9 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Other Non-Current Liabilities are $13.9 billion (Q2 2025), $14.2 billion (Q4 2024), and $5.9 billion (Q3 2024).